^
    21h
    PRESCIENT: Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB (clinicaltrials.gov)
    P2, N=156, Active, not recruiting, Brigham and Women's Hospital | Recruiting --> Active, not recruiting
    Enrollment closed
    |
    CD4 (CD4 Molecule)
    |
    rifampicin
    1d
    PRiMe: Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women (clinicaltrials.gov)
    P1, N=60, Not yet recruiting, McGill University Health Centre/Research Institute of the McGill University Health Centre | Initiation date: Oct 2025 --> Apr 2026
    Trial initiation date
    |
    rifampicin
    2d
    Shorter and Safer Treatment Regimens for Latent TB (clinicaltrials.gov)
    P2/3, N=1800, Recruiting, McGill University Health Centre/Research Institute of the McGill University Health Centre | Not yet recruiting --> Recruiting
    Enrollment open
    |
    rifampicin
    11d
    A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets (clinicaltrials.gov)
    P2, N=60, Recruiting, WestVac Biopharma Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open
    |
    rifampicin
    12d
    The efficacy and complications of rifampin-combined antibiotic therapy for staphylococcal periprosthetic joint infections: A multicenter, randomized controlled trial (ChiCTR2500114844)
    P=N/A, N=428, Not yet recruiting, The First Affiliated Hospital of Fujian Medical University; The First Affiliated Hospital of Fujian Medical University
    New trial
    |
    rifampicin
    15d
    A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet (clinicaltrials.gov)
    P1, N=28, Not yet recruiting, Guangzhou Lupeng Pharmaceutical Company LTD.
    New P1 trial
    |
    itraconazole • rifampicin • rocbrutinib (LP-168)
    20d
    ToxZid: Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis (clinicaltrials.gov)
    P=N/A, N=280, Recruiting, Albert Einstein College of Medicine | Not yet recruiting --> Recruiting | Trial completion date: Sep 2029 --> Dec 2029 | Trial primary completion date: Mar 2029 --> Jun 2029
    Enrollment open • Trial completion date • Trial primary completion date
    |
    rifampicin
    21d
    SIM0270-104: An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants (clinicaltrials.gov)
    P1, N=60, Recruiting, Jiangsu Simcere Pharmaceutical Co., Ltd.
    New P1 trial
    |
    SCR-6852 • itraconazole • midazolam hydrochloride • rifampicin
    22d
    PORT: Pragmatic Optimized Rifampicin Trial (clinicaltrials.gov)
    P3, N=164, Recruiting, Radboud University Medical Center | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Dec 2026
    Trial completion date • Trial primary completion date
    |
    rifampicin
    28d
    RIFREE: Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve Endocarditis (clinicaltrials.gov)
    P3, N=422, Not yet recruiting, Nantes University Hospital
    New P3 trial • Head-to-Head
    |
    rifampicin
    1m
    VA INTREPID: Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics (clinicaltrials.gov)
    P4, N=843, Completed, VA Office of Research and Development | Active, not recruiting --> Completed
    Trial completion
    |
    rifampicin
    1m
    Drug-drug Interaction Study of Rifampin and Anaprazole Sodium (clinicaltrials.gov)
    P4, N=24, Not yet recruiting, Xuanzhu Biopharmaceutical Co., Ltd.
    New P4 trial
    |
    rifampicin